PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

44,651 stories, page 620 of 745

Advanced search
🌍discoverynews.google.comTier 3 · Aggregated media

Vistagen (NASDAQ: VTGN) Phase 3 fasedienol trial misses main goal but shows severe-SAD signal

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Candel Therapeutics Announces Initiation of Global Pivotal Phase 3 AURORA Trial Evaluating Aglatimagene Besadenovec (CAN-2409) in Advanced Non-Small Cell Lung Cancer Patients with Inadequate Response to Immune Checkpoint Inhibitors

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Seizes, Destroys Food Worth Rs 13.71 Lakh in Pune, Solapur Crackdown

Punekar NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Nauticus Robotics, Inc. has announced the completion of a debt restructuring agreement.

BitgetOriginal source
🇫🇷Regulatoryleem.orgTier 1 · Regulatory source

L’industrie pharmaceutique poursuit son engagement en faveur de l’insertion et de l’emploi des personnes en situation de handicap

LEEM FranceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Definium’s Phase 3 LSD Win Is Real. The Fracture It Exposed Is Bigger.

The Clinical Trial VanguardOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Candel opens global phase 3 AURORA trial in lung cancer

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Vistagen Announces Topline and Post-Hoc Data from PALISADE-4 Phase 3 Public Speaking Challenge Trial of Fasedienol for the Acute Treatment of Social Anxiety Disorder

Business WireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Stoke enrolls 162 patients in Phase 3 Dravet study

Stock TitanOriginal source
🌍discoverynews.google.comTier 2 · Trade media

FDA hits Praxis with 3-month delay for epilepsy drug verdict

BioSpaceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Delaware court throws out biotech IPO derivative suit

ICLGOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

US FDA declines to approve Unicycive’s drug to treat elevated phosphate levels in dialysis patients

KELO-AMOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

New Danish biotech company aims to turn new brain biology into business: "Now we'll see if we can make it fly"

medwatch.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Palvella Therapeutics Appoints Accomplished Rare Disease Biotech Executive and Commercial Leader Matt Pauls, J.D., M.B.A., to Board of Directors

Yahoo Finance SingaporeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Unicycive Therapeutics Receives Complete Response Letter from FDA Regarding Resubmitted Oxylanthanum Carbonate (OLC) New Drug Application (NDA)

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Mag 7 Action Improves, But Biotech Keeps Delivering the Real Wins

TheStreet ProOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Unicycive’s kidney drug hits FDA setback as label talks continue

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Unicycive Therapeutics Receives Complete Response Letter

GlobeNewswireOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: HB-086 and HB-097 for Treatment of Chronic Sensory Neuronal Disorders - Neuropathic Pain and Hearing Loss

CORDISOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Thalamic Nuclei Connectivity in the Psychosis Continuum: Parsing Clinical Heterogeneity and Individual Trajectories

CORDISOriginal source
🌍discoverynews.google.comTier 2 · Trade media

BMS-backed Beeline 'putting worker bee mentality into effect' with $126M series A extension

Fierce BiotechOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biotech ETF (BBC) Touches a New 52-Week High

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FinancialContent - Sizzling Stocks Under $5: UPC, ANY, NNBR, DCOY Target AI Infrastructure, Data Centers, Pharmaceutical Innovation and Biotechnology Growth

FinancialContentOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Rats, cockroaches, rotting food: FDA suspends six Mumbai eateries in hygiene crackdown

The Indian ExpressOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Hazmat situation contained at Keystone Research and Pharmaceutical in Cherry Hill, New Jersey

6abc PhiladelphiaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

India's First Homegrown Antibiotic Zaynich Gets US FDA Approval; Here's What You Need To Know About The Drug

NDTVOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biotech ETF (BBC) Touches a New 52-Week High

Zacks Investment ResearchOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

India's First Homegrown Antibiotic Zaynich Gets US FDA Approval; Here's What You Need To Know About The Drug

NDTVOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Obesity drugs after the gold rush

The Pharma LetterOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

BeOne's BRUKINSA cuts progression risk 43% in frontline lymphoma

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Long-term outcomes of adjuvant metronomic capecitabine in locoregionally advanced nasopharyngeal carcinoma: a randomized, controlled, multicenter, phase 3 study

NatureOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Can Hansoh Pharmaceutical Monetize Its Expanding Drug Portfolio?

marketscreener.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Mass. biotech IPO proceeds near $3.2B, close in on pandemic-era record pace

The Business JournalsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Salipro Biotech Announces Publication in Nature Scientific Reports on Expanding DEL Screening to Membrane Proteins

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Lonza USA Eyes $1 Billion Clermont County Biotech Plant, Ohio

Construction ReviewOriginal source
🌍discoverynews.google.comTier 2 · Trade media

HLTH Europe 2026: Healthcare implementation key amid European innovation rush

Pharmaceutical TechnologyOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

UKHSA Evaluation Strategy

This Evaluation Strategy sets out UKHSA’s organisation‑wide approach to planning, conducting and usi...

UK Health Security AgencyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Russia and Cuba set up first joint pharmaceutical venture

Новости GxPOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to book forward of PROTO SCRIPT PHARMACEUTICAL CORP – OTC:PSCR

TradingViewOriginal source
🇺🇰Industrycongenica.comTier 1 · Company source

Genomic Decision Support for Precision Medicine | Congenica

CongenicaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

French biotech stock soars 40% after new data on experimental medicine

CNBCOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Adragos signs agreement with Towa Pharmaceutical to supply off-patent medicines

Manufacturing ChemistOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Joint Statement on Warning to Pharmacists About Diverted HIV Medicines Being Sold on Online Pharmacy-to-Pharmacy Platforms

24-7 Press Release NewswireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FIRST AID: Biotech battle moves to Parliament

EuractivOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Towards an EU clinical trials competitiveness initiative: restoring Europe's edge

The Parliament MagazineOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to revenue forward of Takeda Pharmaceutical Co. Ltd. – TSE:4502

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Genmab’s Epcoritamab Plus Lenalidomide Meets Phase 3 Goal in Relapsed DLBCL

The Clinical Trial VanguardOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Number of shares and votes in Active Biotech

marketscreener.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Number of shares and votes in Active Biotech

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Rats, cockroaches found in 6 Mumbai restaurants, FDA suspends licences

RediffOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBITDA forward of HaTinh Pharmaceutical Joint Stock Co – UPCOM:HDP

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Mumbai food dept finds rats, cockroaches, expired food at six eateries located in Nariman Point, Borivali,

The Economic TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to earnings forward of HaTinh Pharmaceutical Joint Stock Co – UPCOM:HDP

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to book forward of Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Class A – SZSE:300357

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to book forward of HaTinh Pharmaceutical Joint Stock Co – UPCOM:HDP

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to sales forward of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Class A – SSE:600196

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Price to earnings forward of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Class A – SSE:600196

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of Burning Rock Biotech Ltd. Sponsored ADR – DUS:6BU0

TradingViewOriginal source
🇺🇸Regulatoryfda.govTier 1 · Regulatory source

Implantable Marker Recall: Hologic Removes BioZorb 3D Bioabsorbable Markers due to Risk for Patient Complications

BioZorb Markers are implantable and used to mark soft tissue for procedures. They are being recalled...

FDA MedWatchOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Doctor at OU Health leads new clinical trial for stage 1 lung cancer patients

KFOR.comOriginal source